By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tobira Therapeutics Inc. 

214 Carnegie Center
Suite 306
Princeton  New Jersey  08540  U.S.A.
Phone: 609-897-1102 Fax: n/a


SEARCH JOBS








Company News
Tobira Therapeutics Inc. Announces Appointment Of Ian Clements As Vice President, Investor Relations And Corporate Communications 6/23/2015 7:58:30 AM
Tobira Therapeutics Inc. Completes Patient Recruitment For CENTAUR Phase 2b Study Of Cenicriviroc In NASH With Liver Fibrosis 6/8/2015 6:20:01 AM
Tobira Therapeutics Inc. To Present At Upcoming Investor And Scientific Conferences In June 2015 6/1/2015 11:33:45 AM
Tobira Therapeutics Inc. To Present At The Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/11/2015 7:56:43 AM
Tobira Therapeutics Inc. Completes Financing And Merger With Regado Biosciences, Inc. (RGDO) 5/4/2015 4:08:20 PM
Tobira Therapeutics Inc. Highlights Presentations At The International Liver Congress 2015 4/8/2015 7:40:56 AM
Tobira Therapeutics Inc. Highlights Presentations At The American Association for Study of Liver Diseasess Industry Colloquium For Novel Targets And Therapies In Liver Disease 3/20/2015 8:01:43 AM
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015 7:06:08 AM
Regado Biosciences, Inc. (RGDO) And Tobira Therapeutics Inc. Merger Agreement Conference Call Set For 8:30 A.M. EST Today, Jan. 20 1/20/2015 7:59:14 AM
Tobira Therapeutics Inc. Doses First Subject In Phase 1 Clinical Trial Of Cenicriviroc And Pioglitazone 1/20/2015 6:48:12 AM
12345
//-->